FBLG
FibroBiologics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.94
−2.77%Leverage
- Debt / equity
- 0.32x
- Net debt / equity
- -0.44x
- Debt / assets
- 0.18x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 0.12x
Liquidity & coverage
- Current ratio
- 2.64x
- Quick ratio
- 2.64x
- Cash ratio
- 1.59x
- Interest coverage
- -77.81x
- EBITDA / interest
- -79.00x
- Working capital
- $3.6M
Cash & dividend
- FCF / debt
- -10.12x
- Cash flow / debt
- -10.12x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026